皓元医药：公司坚持全球化发展战略

Core Viewpoint - The company is committed to a global development strategy, with operations spanning multiple countries and regions, while maintaining a low revenue share from the European single market [1] Group 1: Business Strategy - The company adopts a differentiated sales model to meet the varying needs of different products, regions, and customer types, primarily utilizing direct sales supplemented by distribution for front-end molecular building blocks, tool compounds, and biochemical reagents [1] - For back-end active pharmaceutical ingredients (APIs) and intermediates, as well as formulation business, direct sales serve as the core approach, with distribution acting as a supplementary channel [1] Group 2: Market Investment - In recent years, the company has increased its investment in the European market, having established a European business center that is now officially operational [1]